Chargement en cours...
F112. PRESCRIBING PATHWAYS TO CLOZAPINE CO-THERAPY WITH ANTIPSYCHOTICS: A SURVEY OF TERTIARY CARE PSYCHIATRISTS TREATING SCHIZOPHRENIA WITH CLOZAPINE AND ADDITIONAL ANTIPSYCHOTICS
BACKGROUND: Clozapine remains the medication of choice for schizophrenia not responsive to monotherapy. For the approximately 30% of clozapine refractory patients there is little evidence to guide the clinician. Ineffective clozapine trials appear to lead to combination therapy, although evidence is...
Enregistré dans:
| Publié dans: | Schizophr Bull |
|---|---|
| Auteurs principaux: | , , , |
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
Oxford University Press
2019
|
| Sujets: | |
| Accès en ligne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6455462/ https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/schbul/sbz018.524 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|